International Burch University at CMBEBIH 2025: Showcasing Innovation and Leadership
Sarajevo, 11–13 September 2025 – International Burch University (IBU) proudly participated in the 6th International Conference on Medical and Biological Engineering in Bosnia and Herzegovina (CMBEBIH 2025), held under the theme “From Science to Business.” As one of the academic partners of the conference, IBU played a central role in shaping scientific dialogue, presenting cutting-edge research, and strengthening the bridge between academia and industry.
Academic Partnership and Representation
IBU is recognised as a long-standing academic partner of CMBEBIH, contributing to programme design, reviewer networks, and student capacity-building initiatives. This year, IBU reinforced its commitment to biomedical innovation and interdisciplinary collaboration through active participation across several key sessions.
Keynote Contributions
On Day 2 (Science in Motion), based on joint research with Prof. Dr. Mersid Poturak (International Burch University), Assist. Prof. Dr. Engin Obucic (International Burch University) delivered a keynote lecture highlighting innovation ecosystems and AI-driven approaches for marketing scientific products in B2B and B2C market segments. His address set the tone for discussions on transitioning scientific discoveries into market-ready solutions.
Research Presentations by IBU Faculty and Collaborators
IBU academics showcased their ongoing projects and collaborative work:
Assoc. Prof. Dr Monia Avdic Obucic chaired the session From Science to Business: Innovation Ecosystem, further underlining IBU’s leadership role in scientific programming.
Joint papers — both those presented by IBU faculty and partners, and those prepared for presentation — included:
- From Laboratory to Market: The BiOptimizers–IBU Partnership as a Model for University–Industry Collaboration (M. Gallant, M. Avdic, E. Obucic, M. Poturak)
- AI-Driven Approaches for Marketing Scientific Products (E. Obucic, M. Poturak)
- Transitioning from Science to Business: Equipping Scientists for Industrial Commercialisation (E. Obucic, M. Poturak).
- Multi-Form Magnesium Supplementation: A Review of Bioavailability, Bioaccessibility, and Purity Considerations with Magnesium Breakthrough as a Case Example (M. Gallant, N. Crnčević, K. Hafner-Vuk, Dž. Kovačić, M. Dizdar, M.Obučić)
- Beyond Generic Probiotics: The Role of Strain Precision, Genetic Optimization, and Microbiome Integration in Probiotic Efficacy (M. Gallant, S. Deumić, Dž. Kovačić, M. Obučić)
- Targeted Imaging Techniques for Microbial Biofilms and Infections: Applications of AFM, MSI, and Radiological Imaging (E. Konjalić, A. Lalović, N. Krdžalić)
- Effect of Trimethoprim-Sulfamethoxazole on Bacterial Growth and Biofilm Formation in Reference Gram-positive and Gram-negative Strains (A. Lavić-Zahirović, I. Jusufović)
- Effect of Subinhibitory Moxifloxacin Concentrations on Biofilm Formation and Antibiotic Resistance in Gram-positive and Gram-negative Bacteria (E. Pramenković, I. Jusufović)
- Effect of Voltaren on the Biofilm Formation and Antibiotic Susceptibility Patterns of Staphylococcus aureus (I. Jusufović, E. Dervišević, E. Avdić, S. Medjedović, A. Elezović)
Capacity-Building and Regional Impact
Through its active involvement, IBU emphasised its mission to foster knowledge transfer, international cooperation, and innovation-driven education. The conference’s international profile—with support from UNESCO, IFMBE, EAMBES, and EIT Health—provided IBU with an excellent platform to showcase its research excellence and expand global partnerships.
Looking Ahead
IBU’s strong representation at CMBEBIH 2025 demonstrates the university’s growing influence in the fields of biomedical engineering, microbiology, and AI-driven research. By contributing to high-level discussions and presenting impactful studies, IBU continues to establish itself as a hub for innovation and collaboration in South-East Europe and beyond.